BioNTech
NEWS
Biotech and pharma companies from across Europe and Asia share company and pipeline updates.
Four biotech companies began trading on the Nasdaq this morning. Here’s a look at today’s launches and one rumored IPO.
Companies from across the globe provide updates to their pipelines and businesses, with news from BioNTech, Mologic, Akcea, RedHill, and more.
In addition to the planned BioNTech IPO, many other pharma and biotech companies in Europe, Asia and elsewhere shared news for the week.
For BioNTech, the IPO will follow a funding round that brought about $270 million into the coffers of the privately-held company.
Biotech and pharma companies from across the globe share data and news in a weekly roundup.
Messenger RNA (mRNA) is a family of RNA molecules that transport genetic information from DNA to the ribosome, where it specifies the amino acid sequence that creates proteins. In theory, by coding your own mRNA, it should be possible to insert it into the cells and turn them into protein factories churning out whatever drug or molecule you program it to.
BioNTech AG inked a deal with Munich, Germany’s MAB Discovery GmbH to acquire MAB’s operational antibody generation unit. No financial details were disclosed.
Days ahead of the J.P. Morgan Healthcare Conference, Germany-based BioNTech extended its three-year-old collaboration with Sanofi as the companies look to co-develop the first cancer immunotherapy candidate for solid tumors.
JOBS
IN THE PRESS